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ABCG4 belongs to the ABCG subfamily, the members of which are half transporters com-
posed of a single transmembrane and a single nucleotide-binding domain. ABCG proteins
have a reverse domain topology as compared to other mammalian ABC transporters, and
have to form functional dimers, since the catalytic sites for ATP binding and hydrolysis, as
well as the transmembrane domains are composed of distinct parts of the monomers. Here
we demonstrate that ABCG4 can form homodimers, but also heterodimers with its closest
relative, ABCG1. Both the full-length and the short isoforms of ABCG1 can dimerize with
ABCG4, whereas the ABCG2 multidrug transporter is unable to form a heterodimer with
ABCG4. We also show that contrary to that reported in some previous studies, ABCG4 is
predominantly localized to the plasma membrane. While both ABCG1 and ABCG4 have
been suggested to be involved in lipid transport or regulation, in accordance with our previ-
ous results regarding the long version of ABCG1, here we document that the expression of
both the short isoform of ABCG1 as well as ABCG4 induce apoptosis in various cell types.
This apoptotic effect, as a functional read-out, allowed us to demonstrate that the dimeriza-
tion between these half transporters is not only a physical interaction but functional coopera-
tivity. Given that ABCG4 is predominantly expressed in microglial-like cells and endothelial
cells in the brain, our finding of ABCG4-induced apoptosis may implicate a new role for this
protein in the clearance mechanisms within the central nervous system.
Introduction
The ABCG1 and ABCG4 proteins belong to the G subfamily of ATP binding cassette (ABC)
transporters. Unlike most other eukaryotic ABC transporters, these proteins consist of only
one nucleotide binding domain (NBD) and one transmembrane domain (TMD), therefore, are
called ABC half-transporters. Another characteristic feature of the members of the G subfamily
is the reverse domain order, meaning that unlike in most ABC transporters, the NBD is local-
ized at the N-terminus of the proteins.
In full-length ABC transporters the two NBDs cooperatively form the ATP binding sites,
therefore, it is commonly accepted that ABC half-transporters have to dimerize to generate a
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functioning unit. The ABCG2 transporter has been demonstrated to function as a homodimer
or a homomultimer in various systems [1–4]. In contrast, the closely related ABCG5 and
ABCG8 proteins have been shown to function as obligate heterodimers [5–7]. Homodimeriza-
tion of ABCG1 has also been suggested previously by co-immunoprecipitation, non-reducing
SDS-PAGE, and cross-linking [8–10].
Since ABCG1 and ABCG4 share 72% overall amino acid identity, heterodimerization of these
proteins has also been predicted [11]. This hypothesis is further supported by the observations
that their Drosophila ortholog, theWhite gene product is known to form heterodimers [12]. The
dissimilar tissue distribution of ABCG1 and ABCG4, however, contradicts the implication of
heterodimerization. Merely neuronal tissues, eye, and induced macrophages are the overlapping
regions where both ABCG1 and ABCG4 were detected simultaneously [13–18]. Our previous
observation that the ATPase activity of ABCG1 expressed in Sf9 cells was inhibited by the inac-
tive mutant variant of ABCG4 provided further support for heterodimer formation [19].
Twomajor splice variants of the mammalian ABCG1, which differ in a 12 amino acid-long seg-
ment, have been described [20]. In human monocyte-derived macrophages and Thp-1 cells both
isoforms are expressed, however, the short variant is the predominant form [20, 21]. The murine
ABCG1 lacking the 12 amino acid-long insert, corresponds to short form of human ABCG1 [22].
Regarding their function, ABCG1 and ABCG4 have been suggested to play a role in cellular
lipid/sterol regulation. ABCG1 has been shown to facilitate cholesterol efflux from cells to
HDL particles, and been proposed to participate in generation of HDL particles in concert with
ABCA1 [9, 14, 20, 23]. It should, however, be noted that cholesterol was released form ABC-
G1-expressing cells to LDL, PC vesicles, PC/ApoAI discs, BSA, and cyclodextrin as effectively
as to HDL [9, 14, 20, 23]. We previously demonstrated that the functional ABCG1 induces apo-
ptosis in macrophages and other cell types, providing an alternative explanation for non-spe-
cific cholesterol efflux from ABCG1-expressing cells, and suggesting an unconventional role
for ABCG1 [24]. Both the short and long variants of the human ABCG1 have been shown to
promote cholesterol efflux from cells [21], however, the apoptotic effect of ABCG1 was only
demonstrated by using the long variant [24]. The function of ABCG4 is even more enigmatic.
Due to the high sequence similarity to ABCG1 and its transcriptional regulation by LXR,
ABCG4 has also been proposed to participate in the lipid/sterol regulation in the tissues and
cell types where expressed, i.e., macrophages and various neural cells [13, 14, 25]. However,
studies in ABCG4 knock out mice did not verify this suggestion, since LXR-induced cholesterol
efflux from macrophages was independent of ABCG4 expression [23]. More recently, Murphy
at al. demonstrated that ABCG4 is expressed in megakaryocyte progenitors, and contributes to
the regulation of platelet production via a mechanism, which involves HDL- and ABCG4-de-
pendent cholesterol efflux from this cell type [26].
In the present study, we investigated the dimerization properties of ABCG4, and its interac-
tions with the ABCG1 variants. Based on the homology, high level sequence similarity, and
capability of heterodimerization, we hypothesized similar functions for ABCG1 and ABCG4,
and investigated the apoptotic effects of the various dimers. Using inactive mutant forms and
assessing a functional readout allowed us to demonstrate functional cooperativity between
ABCG1 and ABCG4.
Materials and Methods
Expression of ABCG proteins in mammalian cells and growth curve
analysis
The cDNA of the full-length isoform of ABCG1 (NP_004906.3) and ABCG4 (NP_001135977.1)
were cloned into pEGFP-N1 vector, leaving a stop codon and frame shift between EGFP and the
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encoded protein sequences. The shorter (NP_058198.2), 1998 nucleic acid long isoform of
ABCG1 was generated by site-directed mutagenesis by using GGCCCTCTGAAGAGGACTCCT
CGTCCATGG and CCATGGACGAGGAGTCCTCTTCAGAGGGCC primer pair. The cDNAs of
ABCG1 isoforms were sequenced to confirm the identity with the Pubmed database. The cDNA
of ABCG2 (NP_004818.2) was cloned into the pcDNA3.1 vector. To generate ABCG1, ABCG4
and ABCG2 variants tagged N-terminally with GFP the sequences of the transporters were
cloned into pEGFP-C1vector as describe previously [27]. The HEK293 cells (ATCC) were main-
tained in complete DMEM in humidified CO2 incubator at 37°C. For transfection, 4×10
5, 8×104,
or 4×104 cells were seeded into 6-, 24-well plates (Greiner), or 8-well (Nunc) Lab-Tek II cham-
bers, respectively. After 24h, the transfection was performed by using Fugene HD (Roche)
reagent according to the manufacturer’s instruction. Transfection media were replaced after 8
hours, and the protein expression was verified by immunoblot or immunofluorescence staining
at different time points after transfection.
Growth curve analyses were performed on 24-well plates for a 3-day period following transfec-
tion. Total living cell number was counted at 24, 48, and 72 hours with trypan blue counterstain-
ing. To investigate the change in the expression levels of ABCG proteins in the transfected
cultures, all the cells in the entire well were harvested 24, 48, 72 and 96 hours after transfection
and subjected toWestern blot analysis (see more details below). To generate cell lines stably
expressing ABCG4 or ABCG4K108M, 0.5 mg/ml G418 (Gibco) was added to the culturing medium
48 hours after transfection, the cells were subsequently maintained in this selection medium
changed on a regular basis. The protein expression levels were determined after an 18-day selec-
tion period byWestern blotting. TheMDCKII cell lines (ATCC) stably expressing the myc-
tagged ABCG5 and HA-tagged ABCG8 proteins were generated by retroviral transduction.
Immunoblot experiments
ABCG4-specific monoclonal antibody was developed similarly as described previously for anti-
body against ABCG1 [24]. Briefly, GST fusion protein with the nucleotide binding domain of
ABCG4 was produced, and used for immunization. Sera were screened for ABCG4-positivity
and ABCG1-negativity. Selected mice were sacrificed and hybridoma cells were generated,
cloned and retested. Monoclonal antibody was purified from supernatant of the best clone, and
its isotype was determined, i.e, IgG2a.
Western blot analysis of whole cell lysates were performed as described previously [28] with
some modifications. Briefly, the cells were suspended in 1x Laemmli buffer and sonicated three
times for 10 seconds at 4°C. Samples, containing 40 μg protein or in some indicated cases the
entire cell lysate, were loaded onto a Laemmli-type 7.5% SDS-polyacrylamide gel and separated.
Electroblotting of the proteins onto PVDF membrane was carried out in Tris buffer containing
high concentration of glycine and 4%methanol at 200 mA for 1.5 hour. Immunodetection was
performed by using specific monoclonal antibodies; clone 6G1/7 for ABCG1, clone 19C11 for
ABCG4, BXP-21 (Abcam) for ABCG2, anti-HA (Covance Babco) for epitope-tagged ABCG8
and anti-myc (Roche) for myc-tagged ABCG5. All antibodies were diluted 500-fold in TBS-
Tween-milk buffer. HRP-conjugated goat anti-mouse IgG secondary antibody (Jackson Immu-
noresearch, 1:10.000), and enhanced chemiluminescence technique was applied to detect spe-
cific bands. For loading control, a mouse anti-Na+K+ ATPase antibody (Biomol, 1:1600) was
used, with the exception when the entire cells lysates were subjected to Western blot analysis.
Coimmunoprecipitations
24 hour after transfection, HEK293 cells were scraped from the 6 well plate in lysis buffer (50
mM Tris pH 7.4, 150 mMNaCl, 0.5% NP-40) supplemented with Roche protease inhibitor
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cocktail and 1 mM PMSF. Samples were then sonicated for 10 seconds in an ultrasonicator.
After sonication, whole cell lysates were centrifuged for 10 min at 4°C at 17000g. 1/10 of the
supernatants were precipitated by 4.5% TCA and resolved in Laemmli buffer. 10 μg of appro-
priate antibody (anti-GFP, anti-ABCG1 or anti-ABCG4) had been coupled to 40 μl of protein
G-sepharose slurry for 2 hours at RT and the 9/10 of the supernatant was added and immuno-
precipitated for 2 hours at 4°C on a microtube shaker. Beads were washed three times in PBS
containing 0.5% NP-40 and boiled in 2x Laemmli buffer to elute immunoprecipitated proteins.
Samples were analyzed by Western blot technique as described above.
Immunofluorescence staining
Immunofluorescence staining was carried out as described previously [24] with minor modifi-
cations. Briefly, transiently transfected HEK293 cells were washed in Dulbecco’s modified PBS,
fixed and permeabilized with 4% paraformaldehyde and pre-chilled methanol. Following fixa-
tion, the cells were incubated for 1 hour at RT in blocking buffer (0.2% BSA, 1% fish gelatin,
0.1% TX-100, and 5% goat serum). Samples were then labeled for 1 hour at RT in blocking
buffer containing specific primary antibody. Anti-pan-cadherin, anti-giantin, and anti-cal-
nexin antibodies purchased from Abcam were diluted in blocking buffer in 1:100, 1:500, and
1:100 dilutions, respectively. After a gentle wash, the cells were incubated with species- or iso-
type-specific, AlexaFluor-conjugated secondary antibodies (Life Technologies/Thermo Fisher
Scientific) diluted in blocking buffer (1:250). Green (505–525 nm) and far red (>660 nm) fluo-
rescence images of the immunostained samples were acquired at 488 and 633 nm excitations,
respectively. An Olympus FV500-IX confocal laser scanning microscope with PLAPO 60×
(1.4) oil immersion objective were used for imaging.
Detection of apoptotic cells
For quantitative assessment of apoptosis, the cells were incubated in Annexin V binding buffer
containing 20-fold diluted Alexa Fluor 488-labeled Annexin V (Life Technologies/Thermo
Fisher Scientific) and 5 μMHoechst33342 (Life Technologies/Thermo Fisher Scientific) for 3
min. At least 3 separate fields of view were acquired for each condition by confocal microscopy
using an UPLAPO 40× (0.85) dry objective. Annexin V positive cells and total cell number were
determined on the basis of green and blue fluorescence, respectively. The results were expressed
as percentage of total cell number. For co-staining of apoptotic cells and ABCG4, the cells were
first subjected to Alexa Fluor 647- conjugated Annexin V (Life Technologies/Thermo Fisher
Scientific) (20-fold dilution, 3 min), then fixed and immunostained as described above. To
detect caspase-3 activity and Annexin V positivity in same experiment, the cells were incubated
with 10 μMPhiPhiLuxG2D2 (Calbiochem) and 10% FCS for 20 min, washed twice, then sub-
jected to Alexa Fluor 488-labeled Annexin V in Annexin V binding buffer for 3 min. Results are
expressed as mean ± S.E.M. For statistical analysis, Student's t-test was used to evaluate signifi-
cant differences. (p< 0.01) in comparison with controls.
Results
Dimer formation of ABCG4
To detect ABCG4 expression, we generated a monoclonal antibody against ABCG4 with an
approach that we previously used to raise an antibody against ABCG1, utilizing the GST-fused
N-terminal domain of the ABC protein for immunization [24]. The specificity of the monoclo-
nal antibody was confirmed by Western blot analysis with whole cell lysates from HEK293
cells transfected with ABCG1, ABCG2, or ABCG4, as well as fromMDCKII cells transduced
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with c-myc-tagged ABCG5 and HA-tagged ABCG8 (Fig 1A). For negative controls, cell lysates
from the parental cell line was used. The anti-ABCG4 antibody recognized a single band at the
expected molecular weight (app. 60 kDa) in the ABCG4-containing sample, and did not cross-
react with any other ABCG proteins. Noteworthy, even ABCG1 was not recognized by the
anti-ABCG4 antibody, despite the 72% amino acid identity of these proteins.
To explore whether the ABCG4 protein is glycosylated, ABCG4-expressing cells were
treated with tunicamycin (5 μg/ml, 24 h). Since ABCG2 is known to be glycosylated, ABC-
G2-expressing cells were used for positive control. In HEK cells, ABCG2 is fully glycosylated as
demonstrated in our previous study [27] and also by the appearance of a single band in Fig 1A.
We found that tunicamycin treatment altered the apparent molecular weight of ABCG2, but
had no effect on the migration of ABCG4 (data not shown), implying that ABCG4 is not glyco-
sylated. This finding is in agreement with previous results using a tagged variant of ABCG4
and glycosydase digestion to study ABCG4 glycosylation [20].
Our previous studies on the ATPase activity of ABCG1 implicated that ABCG1 is capable of
forming homodimers and also heterodimers with ABCG4 [19]. To study whether ABCG4
forms a homodimer, we co-expressed GFP-tagged ABCG4 with the untagged protein in
HEK293 cells, and immunoprecipitated the proteins with anti-GFP antibody. In these experi-
ments, the untagged version was expressed in excess to increase the efficacy. Western blot of
the precipitate developed with our anti-ABCG4 antibody clearly demonstrates the dimer for-
mation (Fig 1B). For negative control, a precipitate from cells expressing ABCG4 alone was
used. To prove that the lower band is not a degradation product of GFP-ABCG4, similar exper-
iment was performed with cells expressing GFP-ABCG4 alone (Fig 1B). In control experi-
ments, homodimer formation of ABCG1 and ABCG2 was also demonstrated by using the
same co-immunoprecipitation approach (Fig 1C and 1D).
To examine whether ABCG4 forms heterodimer with ABCG1, the two proteins were co-
expressed in HEK293 cells and immunoprecipitated with the anti-ABCG4 monoclonal anti-
body. From the two isoforms of ABCG1, first the long variant was investigated. Detection of
both ABCG1 and ABCG4 in the precipitate suggests heterodimer formation (Fig 2A). For neg-
ative control, cells expressing ABCG1 alone were used, and ABCG1 was not detected in the
precipitate, demonstrating the specificity of the co-immunoprecipitation experiments. Since in
subsequent experiments we used an inactive ABCG1 variant, ABCG1K124M, which contains a
missense mutation in the ATP-binding site of the protein, we also investigated whether this
mutant can also form heterodimer with ABCG4. As demonstrated in Fig 2A, the inactive
ABCG1 variant was also co-immunoprecipitated with ABCG4, demonstrating that the hetero-
dimer formation is not affected by the mutation. The inverse of this experiment, that is immu-
noprecipitation with anti-ABCG1 antibody followed by development with anti-ABCG4
antibody, also verified the heterodimer formation (S1 Fig).
To investigate whether the 12 amino acid long insert has a role in the dimerization, we per-
formed similar co-immunoprecipitation experiments using the short isoform of ABCG1
(ABCG1S) and its inactive form. We found that these variants also co-immunoprecipitated
with ABCG4 (Fig 2B). In control experiments, ABCG2 and its inactive form, ABCG2K86M were
co-expressed with ABCG4 in HEK293 cells. As demonstrated in Fig 2C, none of the ABCG2
variants associated with ABCG4. Our results indicate specific physical interaction of ABCG4
with both the full length and the short variant of ABCG1.
Subcellular localization of ABCG4
Despite the increasing number of publications on ABCG4, only a few studies examined the
subcellular localization of this protein, even though there is no consensus in this regard. To
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explore this issue, we transfected HEK293 cells with ABCG4, and immunostained them with
our anti-ABCG4 antibody. We found that ABCG4 was predominantly localized to the plasma
membrane, which was reinforced by ABCG4 colocalization with cadherin, a plasma membrane
marker (Fig 3A). Some additional intracellular staining was observed, which was overlapping
with the immunostaining of the Golgi apparatus-resident protein, giantin. In contrast, the
endoplasmic reticulum marker, calnexin showed distinct subcellular localization from that of
the transporter. Since ABCG4 is normally expressed in neural tissues, we also expressed this
protein in cell lines of neural origin, such as N2a and SH-SY5Y, and observed similar subcellu-
lar distribution to that seen in HEK293 cells (data not shown).
We also studied the localization of the inactive mutant form of ABCG4K108M, and found
that this variant exhibited similar subcellular distribution (Fig 3B). A slight difference was that
the plasma membrane localization of the mutant form was even more pronounced. Markedly
different was, however, the morphology of the cells transfected with the wild type or the inac-
tive ABCG4. This finding is in accordance with our previous observations with cells expressing
ABCG1 [24]. The morphological changes, such as rounding up and detachment, seen in cells
Fig 1. Homodimer formation of ABCG4, ABCG1 and ABCG2. (A) We have generated specific antibodies against ABCG1 (αG1)
and ABCG4 (αG4). The specificity of the applied antibodies was confirmed byWestern Blot technique performed with 40 μg of whole
cell lysates from HEK cells expressing ABCG1 (G1), ABCG2 (G2), ABCG4 (G4), or myc-tagged ABCG5 along with HA-tagged
ABCG8 (G5/G8). Parental HEK cells were used as a negative control. (B) Co-immunoprecipitation experiments were performed with
HEK cells co-transfected with GFP-ABCG4 (GFP-G4) and ABCG4 (G4). Single transfected samples served as controls. Cells were
lysed and an anti-GFP antibody was used for immunoprecipitation. Western blots of precipitates were developed by our anti-ABCG4
(αG4) antibody. The protein expressions were also verified (input). The presence of both untagged and GFP-tagged ABCG4 in the
precipitate of co-transfected cells indicates dimer formation. Similar experiments were performed with GFP-ABCG1 (GFP-G1) and
ABCG1 (G1) (C), or GFP-ABCG2 (GFP-G2) and ABCG2 (G2) pairs (D). Like ABCG2, both ABCG1 and ABCG4 can form
homodimers.
doi:10.1371/journal.pone.0156516.g001
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expressing the wt ABCG4 are characteristic of apoptotic cells. These features were not observed
in ABCG4K108M-expressing cells (Fig 3B). N2a and SH-SY5Y cells transfected with the wild
type or inactive mutant ABCG4 exhibited similar morphological characteristics to that seen in
HEK293 cells (data not shown).
Fig 2. ABCG4 forms heterodimer with either isoform of ABCG1. (A) The full-length isoform of ABCG1 (G1) or its inactive mutant
variant (G1KM) was co-expressed with ABCG4 (G4) in HEK293 cells. Cells were lysed, the protein expression was verified (input)
and co-immunoprecipitation was performed using our anti-ABCG4 (αG4) antibody. Both wt ABCG1 and its inactive mutant were co-
immunoprecipitated with ABCG4, indicating heterodimer formation between ABCG1 and ABCG4. (B) Similar results were obtained
with cells co-expressing the short isoform of ABCG1 (G1S) or its non-functional mutant version (G1SKM). (C) In contrast, when cells
were co-transfected with ABCG4 and wild type or the inactive variant of ABCG2 (G2 or G2KM), only ABCG4 was detected in the
precipitate, demonstrating that no heterodimer formation occurs between ABCG2 and ABCG4.
doi:10.1371/journal.pone.0156516.g002
Fig 3. Subcellular localization of ABCG4. The wild type (G4) or the inactive mutant form (G4KM) of ABCG4 was expressed in
HEK293 cells, immunostained with anti-ABCG4 antibody (αG4) and visualized by confocal microscopy. The subcellular
compartments were identified by using specific markers for the plasmamembrane (cadherin), the Golgi complex (giantin), and the
endoplasmic reticulum (calnexin). (A) The wild type ABCG4 protein was predominantly localized to the plasmamembrane, however,
some intracellular staining was also observed, which was co-localized with the Golgi marker. (B) The mutant form (G4KM) exhibited
even more pronounced plasmamembrane localization. Scale bars—10 μm.
doi:10.1371/journal.pone.0156516.g003
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Growth rate and expression levels in ABCG4-transfected cells
Our previous observation of ABCG1-induced apoptosis [24] and the morphological changes
seen in wt ABCG4-expressing cells implies that ABCG4 may also provoke apoptosis. To test
this hypothesis, first we monitored the cell growth in HEK293 cells transfected with wt ABCG4
or its inactive mutant form, ABCG4K108M. For comparison, cells expressing wt ABCG1,
ABCG1K124M, and wt ABCG2 were used. Cells transfected with either wt ABCG4 or wt ABCG1
exhibited significantly smaller growth rate than cells expressing their inactive mutant counter-
parts, or wt ABCG2 (Fig 4A). It is noteworthy that wt ABCG1-expressing cells showed slightly
slower growth kinetics than the wt ABCG4-transfected cultures. To investigate the temporal
change in the expression levels of the various ABCG protein variants in the entire cultures, in
parallel experiments, all the cells were collected from the culturing wells at different time points
and subjected to Western blot analysis. We found that the protein levels of wt ABCG4 and wt
ABCG1 rapidly declined, whereas the expression of ABCG4K108M, ABCG1K124M, and wt
ABCG2 persisted (Fig 4B). In accordance with this observation, the expression of wt ABCG4
was lost, when we attempted to generate an ABCG4-expressing stable cell line by three week
long continuous selection with G418 (0.5 mg/ml). In contrast, a cell line stably expressing
ABCG4K108M was successfully established by the same procedure (Fig 4C). Taken together, the
expression of functional (wt) ABCG4 or ABCG1 attenuates cell growth, and represents a selec-
tive disadvantage in the cell cultures.
Functional expression of ABCG4 induces apoptosis
To explore whether ABCG4 expression leads to apoptosis similarly to that seen in ABCG1-ex-
pressing cells, we studied phosphatidyl serine (PS) externalization, an early apoptotic event, in
Fig 4. Growth rate and expression levels in ABCG1- and ABCG4-transfected cells. (A) HEK293 cells were transiently
transfected with ABCG4 (G4), ABCG1 (G1), ABCG2 (G2), or with catalytic site mutant variants of ABCG4 and ABCG1 (G4KM,
G1KM). The cell growth of these cultures was monitored for 72 hours. Cells expressing the wild type ABCG4 or ABCG1 protein
showed inhibited growth capacity as compared to cells expressing the inactive mutants or the wild type ABCG2 (G2). (B) The
expression level of ABCG proteins was also assessed byWestern analysis. The total expression of the transgene rapidly declined in
the cultures transfected with the wild type ABCG4 or ABCG1, whereas stable expression levels were observed in cells expressing
the inactive mutants or the wild type ABCG2. Numbers at the top indicate the elapsed time in hours. (C) Following a three week long
selection with G418, no ABCG4 expression was detected in cultures transfected with wild type protein (G4), whereas expression of
the inactive mutant (G4KM) persisted. For loading control Na+K+ ATPase was used.
doi:10.1371/journal.pone.0156516.g004
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cells transfected with the wild type or the inactive mutant form of ABCG4. In these experi-
ments, we used fluorescently labeled Annexin V, which specifically binds to PS on the cell sur-
face. To quantify the fraction of apoptotic cells in the cultures, 24 hours after transfection we
counted the Annexin V-positive cells, and the total cell number was determined by nuclear
staining with Hoechst 33342 (Fig 5A). For comparison, similar experiments were performed
with cell cultures transfected with ABCG2. PS translocation was initiated by the expression of
functional ABCG4, whereas hardly any apoptotic cells were found in cultures transfected with
either ABCG4K108M or wt ABCG2. 24 hours after transfection, when the Annexin V-binding
assay was carried out, the expression levels of wt ABCG4 and ABCG4K108M were comparable,
as demonstrated in Fig 4B.
The fraction of apoptotic cells in cultures transfected with wt ABCG4 was monitored over
time. The number of apoptotic cells gradually increased until 24 hours after transfection,
Fig 5. ABCG4 induces apoptosis. (A) HEK293 cells were transfected with wild type (wt) ABCG4 or its inactive mutant (G4 or
G4KM, respectively). ABCG2-expressing cells served as a negative control (G2). Apoptotic cells in cultures were visualized by
fluorescently labeled Annexin V (green). Lower panels depict Hoechst 33342 nuclear staining (blue) in the same fields of view.
Similar experiments with the ABCG1 isoforms and their inactive mutant variants are shown in S3 Fig. (B) The quantitative results are
expressed as the percentage of apoptotic cells of total cells. The mean values ± S.E.M. obtained from at least 3 independent
transfections are shown. The fraction of apoptotic cells was significantly larger in cultures transfected with the wt ABCG4 or ABCG1
than in cultures expressing the inactive mutants (KM), or the wild type ABCG2. Asterisks indicate significant differences as
compared to wild type expressing cells (p < 0.01). (C) Co-staining of ABCG4 expression (green) and Annexin V binding (red) in
cultures transfected with wt G4 or G4KM demonstrates the connection between the functional expression of ABCG4 and apoptosis.
(D) Parallel detection of Annexin V binding (green) and caspase-3 activity (red) in cell cultures transfected with wt or inactive mutant
ABCG4 confirmed that the functional ABCG4-induced apoptosis. DIC images on the lower panels demonstrate the presence of cell
in the same fields of view.
doi:10.1371/journal.pone.0156516.g005
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subsequently a decline was observed (S2A Fig). The ABCG4 expression, determined by West-
ern blot analysis, showed similar kinetics in the transient transfection system (S2B and S2C
Fig). Dose-response relationship demonstrates a close correlation between ABCG4 expression
and apoptosis (S2D Fig).
In our previous studies, we demonstrated the apoptotic effect of ABCG1, using longer iso-
form of the transporter [24]. To investigate whether the short variant of ABCG1, which is the
predominant form of ABCG1 in humans, also induce apoptosis in cells, we measured Annexin
V binding in cells transfected with both isoforms of ABCG1, as well as with the corresponding
inactive mutant variants. The expression of short isoform of ABCG1 also resulted in high num-
ber of apoptotic cells in the cell culture, similar to that seen in cultures transfected with the full-
length transporter (S3 Fig). Fig 5B depicts the quantitative evaluation of Annexin V-binding
experiments, suggesting that ABCG4 and both isoforms of ABCG1 induce apoptosis, and this
effect depends on the activity of these transporters. In contrast, the expression of the active
form of ABCG2, which is closely related to ABCG1 and ABCG4, has no significant apoptotic
effect.
The ABCG4-induced apoptosis was verified by using additional approaches, i.e., co-staining
of apoptotic cells and ABCG4 expression, as well as assaying the activation of caspase-3 protease
in the ABCG4- transfected cultures. As demonstrated in Fig 5C, Annexin V binding is concomi-
tant with the expression of the functional ABCG4, but not with that of the inactive mutant vari-
ant. In addition, a large number of cells with high caspase-3 activity was detected in cultures
transfected with the wt ABCG4, whereas no caspase-3 activation was seen in cells transfected
with ABCG4K108M, further supporting that the activity of the transporter is required for induc-
tion of apoptosis (Fig 5D).
Functional interaction between ABCG4 and ABCG1
In the experiments shown in Figs 1 and 2, we demonstrated that ABCG1 and ABCG4 can form
both homodimers and heterodimers with one another. The co-immunoprecipitation experi-
ments, however, indicate only physical association between the partners. To explore whether
these transporters functionally interact, we co-expressed the wild type and inactive mutant var-
iants of ABCG1 and ABCG4 in various combinations in HEK293 cells, and assessed the apo-
ptosis as a functional readout. As demonstrated in Fig 6, co-expression of ABCG4K108M with
wt ABCG1 markedly reduced the fraction of apoptotic cells as compared to the cultures trans-
fected with wt ABCG1 alone, suggesting a functional interaction between ABCG1 and ABCG4.
ABCG1K124M also diminished ABCG1-induced apoptosis, but the corresponding inactive
mutant form of ABCG2 (ABCG2K86M) had no effect. To exclude the possibility that the
decreased apoptosis in the co-transfected cultures is due to the reduced expression level of the
wt transporter, we performed a Western blot analysis with single and co-transfected cultures.
The expression of ABCG1 remained unaltered when co-expressed with ABCG4K108M or
ABCG2K86M (S4 Fig).
Similar results were obtained with an inverse experimental arrangement, when the wt
ABCG4 was co-expressed with ABCG1K124M, ABCG4K108M, or ABCG2K86M. ABCG4-induced
apoptosis was diminished by the inactive form of ABCG1 or ABCG4 but not with that of
ABCG2 (Fig 6A). These observations are in accordance with results of the co-immunoprecipita-
tion experiments, demonstrating that ABCG4 forms functional homodimers (Fig 1B) as well as
heterodimers with ABCG1 (Fig 2A), but not with ABCG2 (Fig 2C). To verify the co-expression
of the two proteins in the co-transfected cultures, we performed dual immunostaining, when-
ever isotype differences of the specific antibodies allowed. These experiments demonstrated that
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Fig 6. Functional interaction between ABCG4 and ABCG1. (A) To test the functional interaction between ABCG proteins, the wild
type ABCG1 (G1, upper panels) or the wild type ABCG4 (G4, lower panels) was co-expressed with inactive mutant variants of the
studied ABCG proteins (G1KM, G4KM, or G2KM) as indicated at the top. The apoptotic cells were identified by Annexin V binding
(green). (B) The co-expression of the proteins was confirmed by dual immunostaining wherever isotype difference of the specific
antibodies allowed. ABCG1 expression is shown in green, whereas the partners indicated at the top are depicted in red. (C)
Quantitative evaluation of Annexin V binding experiments revealed that the fraction of the apoptotic cells were significantly reduced
by the co-expression with the inactive mutant variant of ABCG1 (either isoform) or ABCG4, but not with that of ABCG2, as compared
to the cultures expressing wild type (wt) ABCG1 alone. Similar results were obtained with the wild type short isoform of ABCG1, or
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both transfected proteins were expressed and exhibited largely overlapping expression patterns
in these cultures (Fig 6B).
The effect of the inactive mutant variants on the apoptosis induced by ABCG1 or ABCG4
was quantitatively evaluated (Fig 6C). This analysis confirmed the results of the representative
experiments shown in Fig 6A. It is important to mention that in these co-transfection experi-
ments the ratio of applied DNA constructs of wile type vs. inactive mutant form was 1:2. This
biased co-expression helped to form more wt-KM dimers and less wt-wt homodimer, enhanc-
ing the potential inhibitory effect of the inactive mutant form.
Furthermore, the short isoform of ABCG1 was also included in this set of experiments. We
found that the inactive mutant form of ABCG1S reduced the apoptosis induced by the long iso-
form, and vice versa, indicating that these isoforms can functionally interact with one another.
Moreover, ABCG4 can form functional heterodimers with both ABCG1 isoforms, since
ABCG4K108M diminished apoptosis induced by either ABCG1 isoform. Similar to ABCG4 and
the long isoform of ABCG1, the short ABCG1 variant does not seem to interact with ABCG2,
since ABCG2K86M had no effect on the ABCG1S-induced apoptosis.
Despite the fact that there was no obvious difference in the transfection efficacy and expres-
sion levels of ABCG4 and ABCG1, the former protein resulted in three-fold less apoptotic cells
in the cell cultures. The short variant of ABCG1, however, induced apoptosis to an extent simi-
lar to that was observed in cultures transfected with the long ABCG1 isoform, suggesting that
the 12 amino acid-long insert is not required for this function.
Discussion
Although ABCG1 and ABCG4 are closely related to ABCG2, which is a widely studied, well-
characterized ABC transporter, numerous basic issues about ABCG1, and especially ABCG4,
are still unclear or disputed. Our present study focuses on some fundamental characteristics of
ABCG4, addressing several open questions about this enigmatic ABC protein.
One of these unresolved issues is the subcellular localization of ABCG4. Most mammalian
ABC transporters reside in the plasma membrane, and mediate the transport of substances
from the cell interior to the external space. However, several ABC transporters are known to
localize and function in intracellular compartments. An evident example for this is the ER-resi-
dent TAP1/TAP2 transporter dimer, and members of the ABCD subfamily are also intracellu-
larly functioning transporters. In addition, the localization of some ABC transporter, e.g. the
ABCB6 half-transporter is heavily disputed [29, 30]. Overexpression of plasma membrane resi-
dent proteins may also lead to their accumulation in unconventional cellular locations. For
example, ABCC1/MRP1 was shown to sequestrate drugs in intracellular compartments, when
overexpressed [31]. By all means, membrane transporter proteins travel through several cellu-
lar compartments during their life span, even though their business end is not necessarily in
those organelles. As an example, ABCB11/BSEP continuously cycles between the apical surface
and recycling endosomes in the hepatocytes [32]. Moreover, a major fraction of this trans-
porter, which is commonly thought to be a plasma membrane-resident protein, is localized to
the intracellular endosomal pool [33]. It has been reported for several other ABC proteins,
including ABCC2, ABCG1, and ABCG2, that a fraction of transporter is localized to recycling
endosomes [34–36].
Most members of the ABCG subfamily, such as ABCG2 and ABCG5/ABCG8, are thought
to function in the plasma membrane, whereas the cellular target of ABCG1 is controversial.
with wt ABCG4. Asterisks represent significant differences as compared to the cultures expressing the wild type protein alone
(p < 0.01).
doi:10.1371/journal.pone.0156516.g006
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Our previous study on ABCG1 demonstrated predominant plasma membrane localization
[24], which is in agreement with the results of numerous other groups [7, 10, 20, 37–39]. Con-
trary, several studies reported that ABCG1 localizes intracellularly and proposed a functional
role for ABCG1 in the endosomal system [9, 16, 35, 40, 41]. However, it has recently been
reported that a mutant form of the ABCG1 was used in one of these studies, and the substitu-
tion of Leu to Pro at position 550 and 562 in the murine and human ABCG1, respectively,
alters its plasma membrane localization, and the mutant form localizes intracellularly [42].
Interchange between the intracellular ABCG1 pool and the cell surface has also been suggested
[8, 23], although it has been questioned by others [39].
The subcellular localization of ABCG4 is also disputed. Tarr et al., when expressing epitope-
tagged ABCG4 in primary neurons, astrocytes and Cos-7 cells, showed endosomal localization
[16], whereas others demonstrated plasma membrane localization of ABCG4 [7, 38]. It should
be noted that tagging may significantly affect trafficking, and thereby the cellular localization
of a membrane protein. Most studies reporting intracellularly localized ABCG1 also used epi-
tope-tagged versions of the transporter [8, 9, 16, 40, 41]. Endogenous expression of ABCG4
was demonstrated in megakaryocyte progenitors, where ABCG4 was found predominantly in
the Golgi and trans-Golgi compartments [26]. Although the results have been interpreted
differently, taking a closer look at the subcellular localization experiments of this study, a sub-
stantial fraction of ABCG4 can be observed in the endosomal system and even in the plasma
membrane.
In the present work, we analyzed the cellular distribution of untagged ABCG4 by using a
highly specific antibody, which was developed in our laboratory. Predominant plasma mem-
brane localization was observed not only in transfected HEK293 cells, but also in human
(SH-SY5Y) and mouse (N2a) neuronal cells. A smaller fraction of ABCG4 was found in the
Golgi apparatus, which is not surprising for a membrane protein processed in the Golgi. It is
plausible that the accumulation of ABCG4 in the Golgi complex is due to the overexpression of
the protein. However, similar level of overexpression of the inactive mutant variant resulted in
selective plasma membrane localization. Considering that the active ABCG4 triggers apoptosis,
the expression seen in the Golgi complex can also be a consequence of the morphological
changes concomitant with apoptosis. Interestingly, as mentioned earlier, endogenous expres-
sion of ABCG4 was also seen in the Golgi and trans-Golgi compartments in megakaryocyte
progenitor cells [26]. In addition to that seen in the plasma membrane and in the Golgi com-
plex, a small fraction of ABCG4 was found in small punctate structures, which do not co-local-
ize with any of the used markers. These puncta can be either post-Golgi vesicles or recycling
endosomes delivering ABCG4 to the cell surface; or alternatively endocytic vesicles, which
transfer the excess of the protein to the degradation pathway. To explore the course or the
character of these vesicles, further studies involving dynamic experimental approaches are
needed. Using untagged protein and a different approach, our study also verified the finding of
Engel et al., who demonstrated that ABCG4 is likely not glycosylated [20].
Another focus of our study was the dimerization properties of ABCG4 and ABCG1 pro-
teins. Co-immunoprecipitation experiments demonstrated a physical interaction between the
GFP- and non-tagged versions of ABCG4, implying homodimer formation. The ratio of pre-
cipitated proteins was approximately 1:1 (Fig 1B), which suggests dimer formation rather than
oligomerization. Since we applied the untagged version in a great excess to promote the inter-
action, this bias would be reflected at higher degree oligomerization. For instance, 1:3 tagged-
untagged ratio is expected in the case of tetramer formation, etc., which was not observed here.
Similar results were obtained with ABCG1 (Fig 1C), which verifies the homodimerization of
ABCG1 reported in previous studies [8, 10].
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In addition to a physical interaction, we exploited the apoptotic effect of these ABC half
transporters as a functional readout. The inactive mutant variant of ABCG4 diminished the
apoptosis induced by the wild type ABCG4, and similarly the inactive ABCG1 blocked the
ABCG1-stimulated apoptosis. These results demonstrate not just a physical interaction, but
the intimate functional cooperativity between the two halves of the dimers. In addition, we
demonstrated that the short isoform of ABCG1, which is the predominant version in humans,
also forms homodimers. Moreover, this protein is capable of dimerizing with the full-length
ABCG1.
It is plausible to assume that ABCG1 and ABCG4 can also form heterodimers. They share
72% amino acid identity, and have partially overlapping tissue distribution [15, 16, 18]. Closely
related ABC half transporters, such as ABCG5 and ABCG8 are obligate heterodimers [6], and
the Drosophila orthologues of ABCG1 are known to form heterodimers. Both co-immunopre-
cipitation and the functional assays confirmed the heterodimer formation between ABCG4
and either isoform of ABCG1. Inhibitory effect of the inactive half transporters (ABCG4K108M,
as well as the long and short forms of ABCG1K124M) on ABCG4-induced apoptosis also dem-
onstrates that the function leading to apoptosis requires both nucleotide-binding domains to
be active. In a previous study using epitope-tagged variants, detectable amounts of ABCG1 and
ABCG4 were seen in the immunoprecipitates pulled down with GFP-tagged ABCG2 [20].
Despite this, the authors do not support the idea of heterodimerization of ABCG2 with
ABCG1 or ABCG4. Our study demonstrates that no interaction with ABCG2 is formed with
either ABCG4 or ABCG1, since no ABCG2 was detected in the immunoprecipitated samples
even with a Western blot analysis using an extreme long exposition time (data not shown). The
advantage of our system over the previous study, that no tagging was applied in our study.
A previous study by Sano et al. demonstrated that ABCG1 and ABCG4 are localized to two
distinct plasma membrane domains. ABCG1 was found in membrane rafts resistant to both
Triton X-100 and Brij 96, whereas ABCG4 resides in rafts resistant to Brij 96 only and solubi-
lized by Triton X-100 [38]. Moreover, ABCG1 co-localize with flotillin-1, while ABCG4 does
not. Whether the ABCG1/ABCG4 heterodimer prefers the Triton X-100-resistant raft or local-
ized to the same membrane domain as the ABCG4 homodimer, or to both, remains an open
question. It is also unknown whether interchange between these different membrane domains
takes place. The most plausible model for heterodimer formation is that the monomers are
assembled in the endoplasmic reticulum and delivered together to the cell surface; however,
there is no data available that exclude the possibility of reassembly of ABC half transporter
dimers in the target compartment.
Heterodimer formation is frequently concomitant with similar transcriptional regulation.
For instance, the ABCG5 and ABCG8 possess a common promoter, which transcription is
induced by LXR [43, 44]. The expression of both ABCG1 and ABCG4 genes were also reported
to be upregulated in response to LXR and RXR agonists in several studies [13, 14, 17, 21, 24, 25,
45]. However, in certain cell types, such as oligodendrocytes and placental endothelial cells,
only ABCG1 but not ABCG4 was induced by LXR agonist [46, 47]. Previous studies suggested
that ABCG1 and ABCG4 can be co-expressed in the central nervous system and the eye [15,
16, 18], however, these studies have not directly shown interactions between these proteins.
Our study clearly demonstrate both physical and functional interactions between ABCG4 and
ABCG1, suggesting that heterodimer formation may occur in tissues, where both proteins are
expressed.
Similarly, to ABCG1, ABCG4 has been proposed to participate in lipid metabolism, since
the mRNA expression level of ABCG4 was induced by LXR agonists in several cell types,
including human primary macrophages, Thp-1 cells, megakaryocyte progenitors, and neuronal
cells [13, 14, 17, 25, 26]. However, no induction by LXR was found in certain cell types,
Functional Cooperativity between ABCG4 and ABCG1
PLOSONE | DOI:10.1371/journal.pone.0156516 May 26, 2016 14 / 21
including astrocytes, placental endothelial cells, and oligodendrocytes [15, 46, 47]. Heterolo-
gous expression of mouse ABCG4 in HEK cells resulted in increased HDL-dependent choles-
terol efflux [14]. In addition, the level of certain sterols was found to be elevated in the brain of
ABCG4-depleted mice [15, 18]. Despite these findings, the role of ABCG4 in sterol/lipid
metabolism remains unclear. Cholesterol efflux from macrophages of wild type and ABCG4
knock-out mice was identical, and LXR-induced cholesterol efflux was independent of the
presence of ABCG4 [23]. A more recent study suggested a protective role for ABCG4 in the
defense against thrombosis and atherosclerosis [26]. In the proposed model, ABCG4, residing
in the Golgi and trans-Golgi compartments of megakaryocyte progenitor cells, promotes cho-
lesterol transfer to HDL. Decrease in the membrane cholesterol content is sensed by the LYN
kinase, activating E3 ligase c-CBL, which results in the down-regulation of the thrombopoietin
receptor c-MPL. This series of events ultimately leads to the suppression of the megakaryocyte
progenitor proliferation and diminishing of platelet production [26]. This model is in line with
the long-established idea of the intimate relationship between cholesterol metabolism and pro-
liferative responses.
Our observations suggest an alternative role for ABCG4. The altered cell morphology,
reduced cell growth capacity, high number of Annexin V positive cells, and elevated caspase-3
activity together demonstrate that the expression of ABCG4 is associated with apoptotic cell
death. Similar apoptotic effect induced by the long isoform of ABCG1 has previously been
reported by our group [24]. Here we demonstrate the first time that the short isoform of
ABCG1, which is the predominant form in humans, also induces apoptosis. The apoptotic
effects of these ABC half transporters are clearly connected with their function, since i) the cat-
alytic site mutant variants (ABCG4K108M and ABCG1K124M) do not elicit apoptosis, and ii) co-
expression with the inactive mutants attenuates the apoptosis induced by the wild type forms.
Although about three-fold more apoptotic cells was observed in ABCG1-expressing cells than
in the ABCG4-transfected cultures (13.6±0.91% vs. 4.45±0.38%), only a slight difference is
seen in the growing curves shown in Fig 4A. With the given numbers, the ratio of non-apopto-
tic cells in the two cultures is about 0.9, therefore, only a small difference in the growth kinetics
is expected despite the substantial difference in the number of apoptotic cells.
How the functional expression of these ABCG proteins lead to programmed cell death,
remains elusive. One possible explanation is that overexpression of these transporters put an
energy burden on the cells, and ATP depletion results ultimately in apoptosis. However, the
basal ATPase activity of ABCG4 determined in Sf9 membranes is much smaller than that of
ABCG2 [19], and the overexpression of the latter protein did not lead to apoptosis (Fig 5B).
Thus, this explanation seems unlikely. Nevertheless, a connection between activation of LXRα
and apoptosis induction has been previously reported. Neuroblastoma cells treated with LXR
agonists showed signs of apoptosis, as well as increase in both pro-apoptotic gene expressions
and reactive oxygen species (ROS) production [48]. Thus, a plausible explanation for our
observation is that these LXR-inducible gene products, ABCG1 and ABCG4, are associated
with ROS production, which results in cell damage. However, no detectable elevation in ROS
levels in ABCG1- and ABCG4-transfected cells was observed in our hands (data not shown).
The apoptotic effect of ABCG4 and ABCG1 shown in our experiments seemingly contra-
dicts previous observations suggesting a role for these proteins in cellular efflux of lipids and
sterols. However, these two phenomena can be reconciled if we consider that deprivation of
lipid/sterol levels of cells distracts cellular homeostasis, which leads to programmed cell death
[49, 50]. This is also in line with the previously mentioned observation that induction with
LXR agonists is concomitant with elevation in the expression of pro-apoptotic genes [48]. Con-
sidering that ABCG4 and ABCG1 are localized to the plasma membrane, and potentially
involved in lipid and sterol transport, they may change local microenvironment of the
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membrane, causing alterations in the distribution of adhesion molecules and/or assembly of
adhesion complexes. This may ultimately lead to detachment-induced programmed cell death,
which has been termed anoikis [51, 52].
To explore the question, whether the apoptotic effects of ABCG4 and ABCG1 observed in
in vitro systems has a physiological relevance, the expression pattern of these transporters
ought to be taken into account. In general, both transporters are expressed in macrophage-type
cells. ABCG1 is present in monocyte-derived macrophages and Kupffer cells, liver-specific
macrophages, whereas ABCG4 is expressed in certain cells of the central nervous system, e.g.,
microglial cells. In addition, ABCG4 was found in megakaryocyte progenitor cells in the bone
marrow [26]. Normally the clearance of apoptotic bodies is very fast and the proteins are effi-
ciently cleaved by proteases during apoptosis, thus it is hard to detect the remnants in vivo.
However, reports proposed a role for ABCG4 in Alzheimer’s disease (AD), demonstrating
increased expression of ABCG4 in microglial-like cells in the brain of AD patients [53]. In
addition, ABCG4-mediated efflux of amyloid-β peptide (Aβ) and expression of ABCG4 in the
brain capillaries were also shown [54]. These results along with our observations may suggest a
role for ABCG4 in a clearance system for the elimination of Aβ peptide and cell debris, which
is an important mechanism to hinder AD development. Most recently, the role of microglial-
driven clearance and microglial apoptosis in AD pathogenesis attracted much attention [55,
56]. Moreover, it has been proposed that elimination of cell debris by microglial cells may con-
tribute to the prevention of multiple sclerosis and other neurological disorders.
The function of ABCG4 in megakaryocyte progenitors has been connected to proliferative
responses in a negative regulatory fashion [26]. ABCG4 deficiency resulted in increased cell
number, and elevated platelet production. Our finding, linking ABCG4 function to apoptosis,
is in line with these observations. Apoptosis is an essential mechanism in the hematopoiesis,
and especially important in development of myeloid cells (reviewed in [57]). In addition to its
proliferative effect, thrombopoietin was shown to inhibit apoptosis of multipotent hematopoi-
etic progenitor cells, megakaryocyte progenitors, and immature megakaryocytes [58–60].
ABCG4 has been reported to reduce thrombopoietin response in the megakaryocyte progeni-
tors [26]. Whether ABCG4-associated apoptosis has a role in the regulation of megakaryocyte
maturation, is an intriguing issue, which requires further studies to be answered.
In summary, we demonstrated that ABCG4 can function either as a homodimer or as het-
erodimer with either long or short isoforms of ABCG1. ABCG4 is predominantly localized to
the plasma membrane, and induces apoptosis in various cells. The apoptotic morphology of
ABCG1-expressing cells was observed by others [37], although no detailed analysis were car-
ried out to explore this phenomenon prior to our study. The mechanism how ABCG4 (or
ABCG1) function leads to programmed cell death remains unclear. However, the uncovered
phenomenon, the ABCG4-induced apoptosis, brings up a novel area to be explored, which
may assist in better understanding of dysfunctional clearance mechanisms in certain neurolog-
ical disorders.
Supporting Information
S1 Fig. Co-immunoprecipitation of ABCG1 and ABCG4 proteins using anti-ABCG1 anti-
body.HEK293 cells were transfected with ABCG4 (to minimize apoptosis in the cultures, the
inactive mutant form, G4KM was used), or co-transfected with G4KM and wt ABCG1 (G1) or
its inactive variant (G1KM). 24 hours after transfection, the cells were lysed and immunopre-
cipitated with anti-ABCG1 (αG1) antibody. The heterodimer formation was investigated by
using anti-ABCG4 (αG4) antibody for development of the Western blots of the precipitates
(lower panels). The protein expressions of G4KM and the ABCG1 variants were verified by
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Western analysis of the cell lysates (input). These results are consistent with the inverse experi-
ments shown in Fig 1, demonstrating heterodimer formation between ABCG4 and ABCG1
variants.
(TIF)
S2 Fig. Parallel detection of apoptotic cells and ABCG4 expression.HEK293 cells were
transfected with ABCG4, and the fraction of apoptotic cells in the culture was determined by
Annexin V binding at the indicated time points following transfection (A). In parallel, the
expression of ABCG4 was assessed by Western blot analysis (B). The relative protein expres-
sion was determined by densitometry using the Na+K+ ATPase for loading control (C). The
dose-effect curve demonstrates close correlation between ABCG4 expression and apoptosis
(D).
(TIF)
S3 Fig. Apoptosis induced by both isoforms of ABCG1.HEK293 cells were transfected with
the full-length (G1) or short isoform (G1S) of ABCG1, or with their inactive mutant variants
(G1KM or G1SKM). Apoptotic cells in cultures were visualized by fluorescently labeled
Annexin V (green). Lower panels depict nuclear staining of the same cell cultures using
Hoechst 33342 dye.
(TIF)
S4 Fig. Expression levels of wt ABCG1 in single- or co-transfected cultures.HEK cells were
transfected with the wt ABCG1 alone, or co-transfected with the inactive mutant variant of
ABCG1 (G1KM), ABCG4 (G4KM), ABCG1S (G1SKM), or ABCG2 (G2KM). Western blots
demonstrate that the expression level of the wt protein is not altered by the presence of the
inactive forms. Elevation in the total expression level of ABCG1 was only observed when the
wild type and the inactive mutant forms of ABCG1 were co-expressed. For loading control the
-Na+K+ ATPase was used.
(TIF)
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